Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Purple Biotech Ltd ADR (NQ: PPBT ) 3.110 -0.100 (-3.12%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 22,212 Open 3.200 Bid (Size) 3.110 (3) Ask (Size) 3.500 (1) Prev. Close 3.210 Today's Range 3.000 - 3.420 52wk Range 3.000 - 28.60 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Friday's After-Market Session Today 16:36 EDT Via Benzinga Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics October 25, 2024 From Purple Biotech Ltd. Via GlobeNewswire Performance YTD -79.82% -79.82% 1 Month -47.11% -47.11% 3 Month -57.65% -57.65% 6 Month -70.66% -70.66% 1 Year -87.95% -87.95% More News Read More Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics October 10, 2024 From Purple Biotech Ltd. Via GlobeNewswire Why Purple Biotech (PPBT) Shares Are Trading Lower July 01, 2024 Via Benzinga Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24 September 18, 2024 From Purple Biotech Ltd. Via GlobeNewswire Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket September 16, 2024 Via Benzinga Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer Research September 10, 2024 From Purple Biotech Ltd. Via GlobeNewswire Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference August 30, 2024 From Purple Biotech Ltd. Via GlobeNewswire PPBT Stock Earnings: Purple Biotech Beats EPS for Q2 2024 August 16, 2024 Via InvestorPlace Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule July 25, 2024 From Purple Biotech Ltd. Via GlobeNewswire Purple Biotech to Host Virtual KOL Event to Discuss Positive Interim Results from Phase 2 Pancreatic Cancer Study with CM24 on July 11, 2024 July 10, 2024 From Purple Biotech Ltd. Via GlobeNewswire Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gross Proceeds July 02, 2024 From Purple Biotech Ltd. Via GlobeNewswire Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds July 01, 2024 From Purple Biotech Ltd. Via GlobeNewswire Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit June 27, 2024 From Purple Biotech Ltd. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 11, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session June 10, 2024 Via Benzinga Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer June 01, 2024 From Purple Biotech Ltd. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session May 31, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 23, 2024 Via Benzinga PPBT Stock Earnings: Purple Biotech Beats EPS for Q1 2024 May 21, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Friday's After-Market Session May 10, 2024 Via Benzinga Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting April 25, 2024 From Purple Biotech Ltd. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session April 22, 2024 Via Benzinga Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024 March 28, 2024 From Purple Biotech Ltd. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
